QA: Neos Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001467652_2019_Neos_Therapeutics_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001467652, Neos Therapeutics Inc

  xvar xval
0 AssetsCurrent 88,678,000
1 IntangibleAssetsNetIncludingGoodwill 14,616,000
2 PropertyPlantAndEquipmentNet 7,914,000
3 remainder_Assets 149,000
4 LiabilitiesCurrent 57,105,000
5 LiabilitiesNoncurrent 46,407,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 64,278,760
8 SellingGeneralAndAdministrativeExpense 14,035,405
9 ResearchAndDevelopmentExpense 8,495,163
10 remainder_Expenses 53,732,072
11 remainder_Revenues 174,797,255
12 remainder_NetIncome 68,931
13 remainder_ComprehensiveNetIncome -4,999
  yvar yval
0 Assets 111,357,000
1 Liabilities 103,512,000
2 Expenses 140,541,400
3 Revenues 174,797,255
4 StockholdersEquity 7,845,000
5 NetIncome 34,324,786
6 ComprehensiveNetIncome 34,322,286
7 BaseVar 265,140,792
8 EconomicCapitalRatiobeforeLimitedLiability 0.479
9 EconomicCapitalRatio 1.86

Edgar->Model Mapping

Feature Distribution

Change over Time